The rate of response to posaconazole was higher among patients with extrapulmonary aspergillosis(53%) than among those with pulmonary aspergillosis(39%), the results indicate.

• 泊沙康唑对肺外曲霉菌病患者疗效（3%25高于肺内曲霉菌病患者疗效（9%25，研究结果表明。